OdronextamabREGN5837odronextamab-mediatednon-Hodgkin lymphomaDLBCLfollicular lymphomadiffuse large B cell lymphoma
…ent strategies are required to achieve durable tumor rejection. Odronextamab, a CD20xCD3 bispecific antibody, has been approved in the EU fo…